Please enable JavaScript to continue using this application.

Compare $TRDA vs $WHWK | Chartloom

Compare

$TRDA vs $WHWK

Entrada Therapeutics Inc · Whitehawk Therapeutics Inc

TRDA

Entrada Therapeutics Inc

WHWK

Whitehawk Therapeutics Inc

Compare $TRDA vs $WHWK

Comparing Entrada Therapeutics Inc and Whitehawk Therapeutics Inc

TRDAEntrada Therapeutics Inc

WHWKWhitehawk Therapeutics Inc

TRDAEntrada Therapeutics Inc

Market cap

$220M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

5.15x

Rev growth (TTM)

-94.1%

YTD performance

-43.6%

52W performance

-8.0%

FCF yield

-61.4%

WHWKWhitehawk Therapeutics Inc

Market cap

$189M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-100.0%

YTD performance

44.3%

52W performance

65.3%

FCF yield

-36.6%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

TRDA

WHWK

Detailed metrics comparison

TRDA

Entrada Therapeutics Inc

WHWK

Whitehawk Therapeutics Inc

Market Cap

TRDA$220M

WHWK$189M

Enterprise Value

TRDA$121M

WHWK$104M

Price

TRDA$5.67

WHWK$3.52

P/E Ratio

TRDAN/A

WHWKN/A

P/S Ratio

TRDA46.97x

WHWK7.56x

EV/Sales

TRDA25.79x

WHWK0.00x

EV/EBITDA

TRDA15.47x

WHWK0.00x

P/B Ratio

TRDA0.90x

WHWK1.15x

P/FCF Ratio

TRDAN/A

WHWKN/A

EV/FCF

TRDA-0.89x

WHWK-1.50x

PEG Ratio

TRDAN/A

WHWKN/A

Forward P/E (NTM)

TRDAN/A

WHWKN/A

Forward P/S (NTM)

TRDA5.15x

WHWKN/A

Revenue (TTM)

TRDA$5M

WHWK$0

Revenue Growth (YoY)

TRDA-94.1%

WHWK-100.0%

Forward Rev Growth

TRDA124.9%

WHWK167.6%

Gross Margin (TTM)

TRDA0.0%

WHWK88.7%

Operating Margin (TTM)

TRDA0.0%

WHWK87.4%

EBITDA Margin (TTM)

TRDA-3686.8%

WHWK0.0%

Net Margin (TTM)

TRDA-3537.7%

WHWK99.4%

FCF Margin (TTM)

TRDA-2883.2%

WHWKN/A

Net Income (TTM)

TRDA$-166M

WHWK$-80M

FCF (TTM)

TRDA$-135M

WHWK$-69M

EPS (TTM)

TRDA-$3.93

WHWK-$0.96

ROE (TTM)

TRDA-5761.0%

WHWK-5389.0%

ROA (TTM)

TRDA-4654.0%

WHWK-4997.0%

ROIC (TTM)

TRDA-5761.0%

WHWK-5389.0%

Cash

TRDA$99M

WHWK$85M

Debt

TRDA$0

WHWK$0

Net Cash/Debt

TRDA$99M

WHWK$85M

Current Ratio (TTM)

TRDA10.89x

WHWK17.38x

Quick Ratio (TTM)

TRDA10.47x

WHWK17.16x

Debt/Equity (TTM)

TRDA0.00x

WHWK0.00x

Debt/Assets (TTM)

TRDA0.0%

WHWK0.0%

Interest Coverage (TTM)

TRDAN/A

WHWKN/A

Net Debt/EBITDA (TTM)

TRDA0.00x

WHWK0.00x

Beta

TRDA-0.22

WHWK0.99

52W Performance

TRDA-8.0%

WHWK65.3%

YTD Performance

TRDA-43.6%

WHWK44.3%

% from 52W High

TRDA-65.5%

WHWK-35.9%

% from 52W Low

TRDA10.1%

WHWK88.2%

Asset Turnover (TTM)

TRDA0.01x

WHWK0.23x

FCF Yield (TTM)

TRDA-61.4%

WHWK-36.6%

Earnings Yield (TTM)

TRDA-75.3%

WHWK-42.2%

Dividend Yield (TTM)

TRDAN/A

WHWKN/A

Rule of 40

TRDA-2,977.3

WHWK-100.0

EV/GP/RG

TRDAN/A

WHWKN/A

Ticker research

View TRDA research View WHWK research

Metric	TRDA Entrada Therapeutics Inc	WHWK Whitehawk Therapeutics Inc
Market & Valuation
Market Cap	$220M	$189M
Enterprise Value	$121M	$104M
Price	$5.67	$3.52
P/E Ratio	N/A	N/A
P/S Ratio	46.97x	7.56x
EV/Sales	25.79x	0.00x
EV/EBITDA	15.47x	0.00x
P/B Ratio	0.90x	1.15x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.89x	-1.50x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	5.15x	N/A
Revenue & Growth
Revenue (TTM)	$5M	$0
Revenue Growth (YoY)	-94.1%	-100.0%
Forward Rev Growth	124.9%	167.6%
Profitability
Gross Margin (TTM)	0.0%	88.7%
Operating Margin (TTM)	0.0%	87.4%
EBITDA Margin (TTM)	-3686.8%	0.0%
Net Margin (TTM)	-3537.7%	99.4%
FCF Margin (TTM)	-2883.2%	N/A
Net Income (TTM)	$-166M	$-80M
FCF (TTM)	$-135M	$-69M
EPS (TTM)	-$3.93	-$0.96
ROE (TTM)	-5761.0%	-5389.0%
ROA (TTM)	-4654.0%	-4997.0%
ROIC (TTM)	-5761.0%	-5389.0%
Financial Health
Cash	$99M	$85M
Debt	$0	$0
Net Cash/Debt	$99M	$85M
Current Ratio (TTM)	10.89x	17.38x
Quick Ratio (TTM)	10.47x	17.16x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-0.22	0.99
52W Performance	-8.0%	65.3%
YTD Performance	-43.6%	44.3%
% from 52W High	-65.5%	-35.9%
% from 52W Low	10.1%	88.2%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.23x
FCF Yield (TTM)	-61.4%	-36.6%
Earnings Yield (TTM)	-75.3%	-42.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-2,977.3	-100.0
EV/GP/RG	N/A	N/A
Ticker research	View TRDA research	View WHWK research

Valuation

P/S Ratio

WHWK

7.56x

TRDA

46.97x

EV/FCF

WHWK

-1.50x

TRDA

-0.89x

Growth & revenue

Revenue Growth TTM

TRDA

-94.1%

WHWK

-100.0%

Forward Revenue Growth

WHWK

167.6%

TRDA

124.9%

Profitability & performance

Gross Margin

WHWK

88.7%

TRDA

0.0%

ROE

WHWK

-5389.0%

TRDA

-5761.0%

FCF Yield %

WHWK

-36.6%

TRDA

-61.4%

52-Week Performance

WHWK

65.3%

TRDA

-8.0%

Detailed metrics comparison

TRDA

Entrada Therapeutics Inc

WHWK

Whitehawk Therapeutics Inc

Market Cap

TRDA$220M

WHWK$189M

Enterprise Value

TRDA$121M

WHWK$104M

Price

TRDA$5.67

WHWK$3.52

P/E Ratio

TRDAN/A

WHWKN/A

P/S Ratio

TRDA46.97x

WHWK7.56x

EV/Sales

TRDA25.79x

WHWK0.00x

EV/EBITDA

TRDA15.47x

WHWK0.00x

P/B Ratio

TRDA0.90x

WHWK1.15x

P/FCF Ratio

TRDAN/A

WHWKN/A

EV/FCF

TRDA-0.89x

WHWK-1.50x

PEG Ratio

TRDAN/A

WHWKN/A

Forward P/E (NTM)

TRDAN/A

WHWKN/A

Forward P/S (NTM)

TRDA5.15x

WHWKN/A

Revenue (TTM)

TRDA$5M

WHWK$0

Revenue Growth (YoY)

TRDA-94.1%

WHWK-100.0%

Forward Rev Growth

TRDA124.9%

WHWK167.6%

Gross Margin (TTM)

TRDA0.0%

WHWK88.7%

Operating Margin (TTM)

TRDA0.0%

WHWK87.4%

EBITDA Margin (TTM)

TRDA-3686.8%

WHWK0.0%

Net Margin (TTM)

TRDA-3537.7%

WHWK99.4%

FCF Margin (TTM)

TRDA-2883.2%

WHWKN/A

Net Income (TTM)

TRDA$-166M

WHWK$-80M

FCF (TTM)

TRDA$-135M

WHWK$-69M

EPS (TTM)

TRDA-$3.93

WHWK-$0.96

ROE (TTM)

TRDA-5761.0%

WHWK-5389.0%

ROA (TTM)

TRDA-4654.0%

WHWK-4997.0%

ROIC (TTM)

TRDA-5761.0%

WHWK-5389.0%

Cash

TRDA$99M

WHWK$85M

Debt

TRDA$0

WHWK$0

Net Cash/Debt

TRDA$99M

WHWK$85M

Current Ratio (TTM)

TRDA10.89x

WHWK17.38x

Quick Ratio (TTM)

TRDA10.47x

WHWK17.16x

Debt/Equity (TTM)

TRDA0.00x

WHWK0.00x

Debt/Assets (TTM)

TRDA0.0%

WHWK0.0%

Interest Coverage (TTM)

TRDAN/A

WHWKN/A

Net Debt/EBITDA (TTM)

TRDA0.00x

WHWK0.00x

Beta

TRDA-0.22

WHWK0.99

52W Performance

TRDA-8.0%

WHWK65.3%

YTD Performance

TRDA-43.6%

WHWK44.3%

% from 52W High

TRDA-65.5%

WHWK-35.9%

% from 52W Low

TRDA10.1%

WHWK88.2%

Asset Turnover (TTM)

TRDA0.01x

WHWK0.23x

FCF Yield (TTM)

TRDA-61.4%

WHWK-36.6%

Earnings Yield (TTM)

TRDA-75.3%

WHWK-42.2%

Dividend Yield (TTM)

TRDAN/A

WHWKN/A

Rule of 40

TRDA-2,977.3

WHWK-100.0

EV/GP/RG

TRDAN/A

WHWKN/A

Ticker research

View TRDA research View WHWK research

Metric	TRDA Entrada Therapeutics Inc	WHWK Whitehawk Therapeutics Inc
Market & Valuation
Market Cap	$220M	$189M
Enterprise Value	$121M	$104M
Price	$5.67	$3.52
P/E Ratio	N/A	N/A
P/S Ratio	46.97x	7.56x
EV/Sales	25.79x	0.00x
EV/EBITDA	15.47x	0.00x
P/B Ratio	0.90x	1.15x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.89x	-1.50x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	5.15x	N/A
Revenue & Growth
Revenue (TTM)	$5M	$0
Revenue Growth (YoY)	-94.1%	-100.0%
Forward Rev Growth	124.9%	167.6%
Profitability
Gross Margin (TTM)	0.0%	88.7%
Operating Margin (TTM)	0.0%	87.4%
EBITDA Margin (TTM)	-3686.8%	0.0%
Net Margin (TTM)	-3537.7%	99.4%
FCF Margin (TTM)	-2883.2%	N/A
Net Income (TTM)	$-166M	$-80M
FCF (TTM)	$-135M	$-69M
EPS (TTM)	-$3.93	-$0.96
ROE (TTM)	-5761.0%	-5389.0%
ROA (TTM)	-4654.0%	-4997.0%
ROIC (TTM)	-5761.0%	-5389.0%
Financial Health
Cash	$99M	$85M
Debt	$0	$0
Net Cash/Debt	$99M	$85M
Current Ratio (TTM)	10.89x	17.38x
Quick Ratio (TTM)	10.47x	17.16x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-0.22	0.99
52W Performance	-8.0%	65.3%
YTD Performance	-43.6%	44.3%
% from 52W High	-65.5%	-35.9%
% from 52W Low	10.1%	88.2%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.23x
FCF Yield (TTM)	-61.4%	-36.6%
Earnings Yield (TTM)	-75.3%	-42.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-2,977.3	-100.0
EV/GP/RG	N/A	N/A
Ticker research	View TRDA research	View WHWK research